METHODS OF ISOLATING T CELL POPULATIONS Read more about METHODS OF ISOLATING T CELL POPULATIONS US Application 17/636,206Filed on 2022-02-17
METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD Read more about METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD Japan2022-011975Filed on 2022-01-28
TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY Read more about TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY Australia2022200267Filed on 2022-01-17
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER Read more about RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER US Patent 12,486,270Filed on 2022-03-11
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER Read more about RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER European Patent20785624.6Filed on 2020-09-11
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER Read more about RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER Canada3153096Filed on 2020-09-11
Glypican 2 As A Cancer Marker And Therapeutic Target Read more about Glypican 2 As A Cancer Marker And Therapeutic Target Japan2021-194050Filed on 2021-11-30
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage Israel290105Filed on 2022-01-25
Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection Read more about Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection Patent Cooperation TreatyPCT/US2022/015349Filed on 2022-02-04
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Hong Kong42022051280.0Filed on 2022-04-07